GlaxoSmithKline said on Tuesday that US health regulators have approved the company's additional medication for severe asthma, paving the way for patients to choose a less frequently used treatment plan to enter the market.

Zhitongcaijing · 18h ago
GlaxoSmithKline said on Tuesday that US health regulators have approved the company's additional medication for severe asthma, paving the way for patients to choose a less frequently used treatment plan to enter the market.